4:16 PM ET
8-K
Leadership Change
Immuneering Leadership Change
Immuneering Corporation appointed Grant C. Bogle, MBA, to its Board of Directors as a Class III Director, effective November 9, 2026. Mr. Bogle will receive compensation under the company's standard non-employee director arrangements and has entered into a standard indemnification agreement.
- Counterparty
- Grant C. Bogle